When was Biocom California founded?

Biocom California was founded in 1995.

Where is Biocom California located?

Biocom California is headquartered in San Diego, United States. It is registered at San Diego, California.

How many employees does Biocom California have?

As of May 31, 2026, the latest employee count at Biocom California is 205.

Is Biocom California a funded company?

Biocom California is a funded company, having raised a total of $***** in its 1st and only funding round.

How much is Biocom California worth?

The last known valuation of Biocom California was $***** as of Sep 13, 2019.

Where does Biocom California rank among its competitors?

Biocom California ranks 5th amongst 803 active competitors, of which 54 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of Biocom California?

Biocom California's top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

Biocom California - 2026 Company Profile & Competitors

Q: Is Biocom California an acquired company?

Biocom California got acquired by Sistema on Sep 13, 2019.

Biocom California is an acquired company based in San Diego (United States), founded in 1995. It operates as a CRO focused on drug discovery & development for multiple therapeutic areas. , with last known valuation of $*****. The company has 803 active competitors, including 54 funded and 47 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.

Company Details

Website: www.biocom.org/
Social
Registered Address: San Diego, California

Key Metrics

Founded Year

1995

Location

San Diego, United States

Stage

Acquired

Last Known Valuation

$***** as on Sep 13, 2019

Ranked

5^th among 803 active competitors

Employee Count

205 as on May 31, 2026

Similar Companies

Alloy Therapeutics & 824 more

Exit Details

Acquired by Sistema (Sep 13, 2019)

View Biocom California's full profile

Biocom California is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOCOM SAN DIEGO CIN: 330496646 , United States, Active	Dec 31, 1999	-	68 (As on Dec 31, 2024)	-

Biocom California got acquired by Sistema on Sep 13, 2019 at an acquisition amount of $*****.

Click here to take a look at Biocom California's acquisition in detail

Biocom California has not raised any funding rounds yet.

Biocom California's employee count trend

Biocom California has 205 employees as of May 26. Here is Biocom California's employee count trend over the years:

Employee count trend for Biocom California

Uncover Biocom California's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biocom California include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Biocom California, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	58/100
5th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	39/100
6th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	54/100
7th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, UVM Health & 4 others	53/100
8th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, ShenZhen GTJA Investment Group & 3 others	51/100
9th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	51/100
10th	Superluminal Medicines 2022, Boston (United States), Series A	Generative biological and chemical company focused on drug discovery	$158M	RA Capital Management, Insight Partners & 5 others	50/100